Boston Scientific Corporation Stock price

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
68.49 USD -0.19% Intraday chart for Boston Scientific Corporation +1.38% +18.47%
Sales 2024 * 15.58B Sales 2025 * 17.01B Capitalization 101B
Net income 2024 * 2.05B Net income 2025 * 2.58B EV / Sales 2024 * 6.84 x
Net Debt 2024 * 5.82B Net Debt 2025 * 2.66B EV / Sales 2025 * 6.07 x
P/E ratio 2024 *
49.6 x
P/E ratio 2025 *
40.3 x
Employees 48,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.64%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.00%
1 week+1.75%
Current month+3.64%
1 month+3.30%
3 months+22.49%
6 months+31.71%
Current year+18.70%
More quotes
1 week
66.91
Extreme 66.911
68.66
1 month
65.52
Extreme 65.52
68.66
Current year
57.11
Extreme 57.11
68.66
1 year
48.35
Extreme 48.35
68.66
3 years
34.98
Extreme 34.98
68.66
5 years
24.10
Extreme 24.1
68.66
10 years
11.10
Extreme 11.1
68.66
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 11-10-16
Director of Finance/CFO 58 96-11-30
Chief Tech/Sci/R&D Officer - 09-08-31
Members of the board TitleAgeSince
Director/Board Member 61 21-06-22
Director/Board Member 69 15-03-31
Director/Board Member 72 14-02-28
More insiders
Date Price Change Volume
24-03-28 68.49 -0.19% 6 424 649
24-03-27 68.62 +1.00% 4,069,747
24-03-26 67.94 +0.97% 5,308,830
24-03-25 67.29 -0.49% 3,321,802
24-03-22 67.62 +0.09% 4,463,370

Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT

More quotes
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (61.5%): products used in cardiology surgeries (28.4% of net sales), cardiac rhythm management (26.8%), peripheral surgeries (24.2%), electrophysiology tests (7.5%) and other (13.1%); - endodontic surgery (31.3%): equipment used in endoscopy (55.6% of net sales) and urology (44.4%); - neuromodulation (7.2%). The United States account for 60.2% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
68.62 USD
Average target price
71.73 USD
Spread / Average Target
+4.54%
Consensus
  1. Stock
  2. Equities
  3. Stock Boston Scientific Corporation - Nyse